|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.08.25 - 15:51
|
Philips: China ist nicht alles (Aktiencheck)
|
|
|
HA AmsterdamWien (www.aktiencheck.de) - Philips-Aktienanalyse der Raiffeisen Bank International AG (RBI):
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Aktie von Koninklijke Philips N.V. (ISIN: NL0000009538, WKN: 940602, Ticker-Symbol: PHI1, Euronext Amsterdam-Symbol: PHIA). [mehr]...
|
|
|
|
|
|
|
|
|
|
|
15.08.25 - 00:54
|
Philips adds Diva Labs to medical display supply chain (Digitimes)
|
|
|
Diva Laboratories, a medical display manufacturer under Qisda Group, has joined the supply chain of Royal Philips and received the company's "Procurement Innovation Partner Health Systems" award. The firm generates over 80% of its revenue from international customers....
|
|
|
14.08.25 - 12:30
|
Headwater Gold Announces Strategic Private Placement with Lead Orders from Rick Rule and Jeff Philips (The Newswire)
|
|
|
Vancouver, British Columbia, August 14, 2025 - TheNewswire: Headwater Gold Inc. (CSE: HWG) (OTCQB: HWAUF) (the "Company" or "Headwater") is pleased to announce that it proposes to undertake a non-brokered private placement (the "Offering") to raise gross proceeds of up to $1,000,000 through the sale of up to 3,333,333 units (each, a “Unit”) of the Company at a price of $0.30 per Unit.
Highlights:
Strategic lead investments from existing shareholders Rick Rule and Jeff Phillips.
One-year hold period on Shares underlying the Units and acceleration trigger for the Warrants.
Proceeds will be used to support ongoing project generation, exploration at the Company's 100% owned gold projects in the Western United States and general working capital.
Caleb Stroup, President and CEO of the Company, states: “We are very pleased to announce strategic investments in Headwater Gold by Rick Rule and Jeff Phillips, two highly respected figures in the natural resource investm...
|
|
|
|
|
|
|
|
|
31.07.25 - 12:42
|
Philips Neutral (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für Philips nach den am 29. Juli vorgelegten Quartalszahlen von 15,30 auf 18,30 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Der Umsatz des Medizintechnikkonzerns sei etwas ......
|
|
|
|
|
30.07.25 - 14:21
|
Philips Hold (DPA-AFX)
|
|
|
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Philips auf "Hold" mit einem Kursziel von 23 Euro belassen. Der Medizintechnikhersteller habe die Erwartungen übertroffen und die Margenprognose aufgrund geringerer Belastungen ......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
